NCT06132828 2026-04-27Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid TumorsZhejiang Doer Biologics Co., Ltd.Phase 1 Recruiting216 enrolled